Gene Therapy Market Revenue 2024 to 2034
Gene Therapy Market Revenue 2024 to 2034
The gene therapy market will surge from USD 9.26 Bn in 2024 to USD 55.43 Bn by 2034, at a 19.6% CAGR, supported by breakthroughs in genetic engineering, rising rare disease treatments, and regulatory approvals.
Report ID: 10652
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 9.26 Bn
Forecast Year,
USD 55.43 Bn
CAGR, 2025 -
19.60%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Gene Therapy Market Size Analysis
Gene Therapy Market Size By Vector Type 2024 to 2034 (USD )
| Vector Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AAV | 2.48 | 2.96 | 3.57 | 4.35 | 5.23 | 6.16 | 7.26 | 7.99 | 9.48 | 12.31 | 16.27 |
| Lentivirus | 2.39 | 2.85 | 3.34 | 4.05 | 4.90 | 5.69 | 7.01 | 8.74 | 10.01 | 11.71 | 14.49 |
| Adenovirus | 3.83 | 4.60 | 5.51 | 6.44 | 7.78 | 9.35 | 11.29 | 13.39 | 16.54 | 19.60 | 22.73 |
| Others | 0.57 | 0.67 | 0.83 | 1.00 | 1.04 | 1.45 | 1.53 | 2.29 | 2.73 | 2.73 | 1.94 |
Gene Therapy Market Size By Delivery 2024 to 2034 (USD )
| Delivery | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| In vivo | 4.16 | 4.99 | 5.90 | 6.97 | 8.51 | 10.11 | 12.56 | 14.39 | 17.83 | 21.65 | 24.86 |
| Ex vivo | 5.10 | 6.09 | 7.34 | 8.87 | 10.43 | 12.54 | 14.54 | 18.01 | 20.92 | 24.69 | 30.57 |
Gene Therapy Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 1.26 | 1.49 | 1.74 | 2.22 | 2.57 | 3.05 | 3.28 | 4.90 | 4.77 | 5.83 | 8.87 |
| Ophthalmology | 3.97 | 4.72 | 5.69 | 6.67 | 8.16 | 9.51 | 11.72 | 13.62 | 16.49 | 20.28 | 22.76 |
| CNS | 3.99 | 4.79 | 5.75 | 6.80 | 8.19 | 9.75 | 11.72 | 13.85 | 16.36 | 20.19 | 23.09 |
| Others | 0.04 | 0.07 | 0.06 | 0.15 | 0.02 | 0.35 | 0.38 | 0.03 | 1.14 | 0.05 | 0.71 |
Gene Therapy Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 2.17 | 2.60 | 3.15 | 3.67 | 4.44 | 5.65 | 6.19 | 7.33 | 8.80 | 10.36 | 12.15 |
| Clinics | 3.99 | 4.78 | 5.64 | 6.87 | 8.19 | 9.52 | 11.81 | 13.96 | 16.56 | 19.46 | 23.91 |
| Research Institutes | 3.09 | 3.70 | 4.46 | 5.29 | 6.31 | 7.49 | 9.10 | 11.11 | 13.39 | 16.53 | 19.37 |
Gene Therapy Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.52 | 3.05 | 3.57 | 4.31 | 5.22 | 5.97 | 7.37 | 9.20 | 10.21 | 11.98 | 14.73 |
| Europe | 0.92 | 1.08 | 1.28 | 1.30 | 1.90 | 2.23 | 3.07 | 3.87 | 4.30 | 2.95 | 4.45 |
| Asia Pacific | 2.68 | 3.21 | 3.86 | 4.73 | 5.47 | 6.58 | 7.59 | 8.84 | 10.57 | 14.71 | 16.55 |
| Latin America | 1.54 | 1.84 | 2.20 | 2.82 | 3.21 | 4.12 | 4.34 | 4.96 | 6.51 | 6.77 | 9.25 |
| Middle East & Africa | 1.60 | 1.90 | 2.32 | 2.68 | 3.14 | 3.75 | 4.73 | 5.53 | 7.16 | 9.93 | 10.45 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
